Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

4.6K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.6K
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

905
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
905
Neurogenesis and Regeneration of Nervous Tissue01:15

Neurogenesis and Regeneration of Nervous Tissue

1.5K
In the CNS, neurogenesis, the birth of new neurons from stem cells, is limited to the hippocampus in adults. In other regions of the brain and spinal cord, neurogenesis is almost non-existent due to inhibitory influences from neuroglia, especially oligodendrocytes, and the absence of growth-stimulating cues. The myelin produced by oligodendrocytes in the CNS inhibits neuronal regeneration. Furthermore, astrocytes proliferate rapidly after neuronal damage, forming scar tissue that physically...
1.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Impact of COVID-19 on Movement Disorders Patients in the Outpatient Setting.

Cureus·2026
Same author

Stem cells enhance mitochondrial function in experimental Huntington's disease.

Stem cells (Dayton, Ohio)·2026
Same author

Apolipoprotein A1 reduces blood-spinal cord barrier leakage, improves astrocytic coverage, and enhances motor neuron survival to restore the neurovascular unit in ALS mice.

Frontiers in aging neuroscience·2026
Same author

Ischemic Penumbra Protection: Beyond Brains or Not.

MedComm·2025
Same author

Stem Cells Run Like Clockwork for Stroke Therapeutics.

Stem cell reviews and reports·2025
Same author

Appropriateness of acute breast symptom recommendations provided by ChatGPT.

Clinical imaging·2025

Related Experiment Video

Updated: Jan 5, 2026

High Throughput Characterization of Adult Stem Cells Engineered for Delivery of Therapeutic Factors for Neuroprotective Strategies
09:19

High Throughput Characterization of Adult Stem Cells Engineered for Delivery of Therapeutic Factors for Neuroprotective Strategies

Published on: January 4, 2015

11.2K

Cell therapy for central nervous system disorders: Current obstacles to progress.

Takao Yasuhara1, Satoshi Kawauchi1, Kyohei Kin1

  • 1Department of Neurological Surgery, Okayama University Graduate School of Medicine, Okayama, Japan.

CNS Neuroscience & Therapeutics
|October 18, 2019
PubMed
Summary
This summary is machine-generated.

Cell therapy shows promise for neurological disorders like Parkinson's and stroke, utilizing induced pluripotent stem (iPS) cells for neurorestoration and drug discovery. Mesenchymal stem cells are also widely used for transplantation due to their trophic properties.

Keywords:
Parkinson's diseasecell therapyiPS cellsstroketraumatic brain injury

More Related Videos

Systemic Injection of Neural Stem/Progenitor Cells in Mice with Chronic EAE
09:24

Systemic Injection of Neural Stem/Progenitor Cells in Mice with Chronic EAE

Published on: April 15, 2014

18.1K
Anatomically Inspired Three-dimensional Micro-tissue Engineered Neural Networks for Nervous System Reconstruction, Modulation, and Modeling
10:45

Anatomically Inspired Three-dimensional Micro-tissue Engineered Neural Networks for Nervous System Reconstruction, Modulation, and Modeling

Published on: May 31, 2017

13.6K

Related Experiment Videos

Last Updated: Jan 5, 2026

High Throughput Characterization of Adult Stem Cells Engineered for Delivery of Therapeutic Factors for Neuroprotective Strategies
09:19

High Throughput Characterization of Adult Stem Cells Engineered for Delivery of Therapeutic Factors for Neuroprotective Strategies

Published on: January 4, 2015

11.2K
Systemic Injection of Neural Stem/Progenitor Cells in Mice with Chronic EAE
09:24

Systemic Injection of Neural Stem/Progenitor Cells in Mice with Chronic EAE

Published on: April 15, 2014

18.1K
Anatomically Inspired Three-dimensional Micro-tissue Engineered Neural Networks for Nervous System Reconstruction, Modulation, and Modeling
10:45

Anatomically Inspired Three-dimensional Micro-tissue Engineered Neural Networks for Nervous System Reconstruction, Modulation, and Modeling

Published on: May 31, 2017

13.6K

Area of Science:

  • Neuroscience
  • Regenerative Medicine
  • Biotechnology

Background:

  • Cell therapy is advancing for central nervous system disorders, including Parkinson's disease, stroke, and traumatic brain injury.
  • Induced pluripotent stem (iPS) cells offer a significant donor source for neurorestoration and drug discovery in neurological diseases.
  • Adult mesenchymal stem cells are commonly used for transplantation due to ease of isolation and trophic factor secretion.

Purpose of the Study:

  • To review milestone achievements in cell therapy for central nervous system disorders.
  • To discuss current translational obstacles for clinical application of cell therapies.
  • To highlight the role of iPS cells and mesenchymal stem cells in neurorestoration.

Main Methods:

  • Literature review of recent advancements in cell therapy for neurological disorders.
  • Analysis of the clinical application and translational challenges of stem cell therapies.
  • Examination of induced pluripotent stem cells and mesenchymal stem cells as therapeutic sources.

Main Results:

  • Significant progress has been made in applying cell therapy to various neurological conditions.
  • iPS cells provide a versatile platform for neurorestoration and therapeutic drug discovery.
  • Mesenchymal stem cells remain a practical choice for transplantation due to their properties.

Conclusions:

  • Cell therapy, particularly using iPS cells and mesenchymal stem cells, holds great potential for treating central nervous system disorders.
  • Overcoming translational obstacles is crucial for the widespread clinical adoption of these therapies.
  • Continued research is essential to fully realize the benefits of cell-based neurorestoration.